Wessely, A.; Zwazl, I.; Poturica, M.; Weseslindtner, L.; Kundi, M.; Wiedermann, U.; Wagner, A.
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults. Vaccines 2025, 13, 737.
https://doi.org/10.3390/vaccines13070737
AMA Style
Wessely A, Zwazl I, Poturica M, Weseslindtner L, Kundi M, Wiedermann U, Wagner A.
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults. Vaccines. 2025; 13(7):737.
https://doi.org/10.3390/vaccines13070737
Chicago/Turabian Style
Wessely, Andrea, Ines Zwazl, Melita Poturica, Lukas Weseslindtner, Michael Kundi, Ursula Wiedermann, and Angelika Wagner.
2025. "Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults" Vaccines 13, no. 7: 737.
https://doi.org/10.3390/vaccines13070737
APA Style
Wessely, A., Zwazl, I., Poturica, M., Weseslindtner, L., Kundi, M., Wiedermann, U., & Wagner, A.
(2025). Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults. Vaccines, 13(7), 737.
https://doi.org/10.3390/vaccines13070737